Microfilaria in the Kidney: An Under-Recognized Cause of Diverse and Aggressive Glomerular Injury in Endemic Regions

Lymphatic filariasis continues to be a major public health problem across tropical and subtropical regions, with India bearing a significant share of the global burden.¹ While the classical manifestations involve the lymphatics and skin, renal involvement remains distinctly uncommon and, perhaps more importantly, under-recognized. While the clinical manifestations are obvious due to the adult filarial worms, virtually all those with microfilaremia have some degree of subclinical disease that includes microscopic hematuria and/or proteinuria, dilated lymphatics which could only be visualized by imaging.²

In this context, the case series by Gupta et al. published in this journal., provides an important contribution by systematically documenting the clinicopathological spectrum of biopsy-proven microfilaria-induced renal injury over a 6-year period.³ In their cohort of seven patients, the authors describe a wide range of clinical presentations including nephrotic syndrome, acute nephritic syndrome, chyluria with or without hematuria, rapidly progressive renal failure, and unexplained renal dysfunction. The histopathological spectrum is particularly striking, encompassing non-proliferative glomerulopathy, membranous glomerulopathy, amyloidosis with non-proliferative GN, and most notably, two cases of crescentic glomerulonephritis – one focal necrotizing, and one diffuse proliferative with neutrophil and eosinophil-rich exudation. This observation expands the recognized spectrum of filarial-associated kidney pathology and challenges the commonly held perception that such involvement is generally mild, incidental or limited to chyluria.

Clinically overt filariasis, characterized by lymphedema and other lymphatic manifestations, is largely attributable to the presence of adult filarial worms within the lymphatic system. In contrast, the earlier microfilaremic phase often follows a more subtle and distinct clinical course and may manifest predominantly through renal abnormalities such as proteinuria and hematuria, with or without overt renal dysfunction. These pathologic changes are mediated by both direct parasitic effects and complex host inflammatory mechanisms, including granulomatous and immune-complex–mediated processes. Progressive lymphatic involvement results from chronic inflammatory injury to the lymphatic vessels, driven by adult worms and the host immune response, culminating in lymphatic dilation, fibrosis, valvular incompetence, and ultimately obstruction. Classic renal manifestations, including chyluria, particularly in Wuchereria bancrofti infection, arise when obstructed retroperitoneal lymphatics rupture into the urinary tract.⁴ Importantly, recognition of filariasis during this pre-lymphatic phase represents a critical window of opportunity. Timely identification and intervention at this stage may not only halt disease progression but also prevent the permanent disfigurement and organ damage that characterize advanced filarial disease. Therefore, in endemic settings, inclusion of filariasis in the differential diagnosis of unexplained proteinuria or renal dysfunction is essential for early, targeted management and meaningful reduction in disease-related morbidity.

The case series by Gupta et al. builds upon existing knowledge and advances the field by providing direct histopathological documentation of microfilariae within both glomerular and peritubular capillaries, implicating the parasite as a potential instigator of a broad spectrum of glomerular injury, ranging from non-proliferative and immune complex mediated patterns to even necrotizing crescentic lesions. Previous case reports have described associations with amyloidosis, membranous nephropathy, minimal change disease, and focal segmental glomerulosclerosis, lending support to an immune complex driven mechanism of injury.^5,6 In the present study, however, the simultaneous identification of microfilariae in glomerular capillaries in six of seven cases and in peritubular capillaries in three cases, together with the accompanying structural damage and positive immunofluorescence findings in a subset, strengthens the argument for a dual pathogenic mechanism. This likely reflects a combination of direct parasitic vascular and capillary obstruction or endothelial injury, along with indirect, immune-mediated glomerular damage driven by circulating parasitic antigens and immune complex deposition. These data strengthen the concept that microfilarial infection exerts a dual pathogenic influence, through direct vascular involvement, and immune-mediated mechanisms culminating in clinically significant renal disease.

From a practical standpoint, this series offers several valuable lessons for clinicians and renal pathologists practicing in endemic regions. Firstly, A high index of suspicion is paramount, with deliberate scrutiny for the parasite on biopsy, as renal involvement in filariasis, though uncommon, often manifests with protean and nonspecific clinical features. In individuals from endemic regions who present with nephrotic syndrome, microscopic hematuria/proteinuria, unexplained renal dysfunction, or crescentic/proliferative glomerulonephritis, particularly in the presence of eosinophil-rich exudates, the possibility of an underlying parasitic etiology should be carefully considered. While only three of the seven patients in this series demonstrated peripheral eosinophilia, the endemicity of filariasis in the region, coupled with prior institutional experience, prompted a vigilant histopathological evaluation that led to the identification of microfilarial larvae within the renal tissue. Microfilaria can easily be overlooked on routine light microscopy if not actively sought. The presence of eosinophil-rich exudation, atypical intraluminal structures, or unexplained capillary occlusion should prompt a thorough and deliberate search for parasitic forms in both glomerular and peritubular capillary networks. Secondly, biopsy may be required in the evaluation of chyluria. Chyluria is not uncommon in endemic clinical settings and typically presents with milky urine or the passage of white flakes, reflecting urinary loss of chyle. On evaluation, patients may demonstrate significant proteinuria and lipiduria, and in chronic disease, particularly among undernourished individuals, hypoalbuminemia may also be observed. Although lymphangioscintigraphy can demonstrate abnormal lymphatic drainage and confirm lymphatic–urinary communication, the presence of concurrent glomerular pathology related to microfilarial infection cannot be reliably excluded on this basis alone.

In such cases, discerning whether proteinuria is solely attributable to chyle leakage or represents an underlying glomerular disease process can be challenging. A renal biopsy, therefore, is not universally required at initial presentation but should be strongly considered in patients who exhibit persistent or progressive proteinuria despite appropriate anti-filarial therapy, unexplained renal dysfunction, active urinary sediment, or other features suggestive of intrinsic glomerular pathology. In these selected cases, histological evaluation becomes critical for identifying underlying lesions, which may in turn justify immunosuppression in addition to antiparasitic treatment.

Therapeutic implications all patients in this series were treated with diethylcarbamazine (DEC), with three receiving additional steroids. Notably, all patients demonstrated either complete or partial remission, highlighting that early recognition of this etiology can lead to meaningful recovery. This is significant in patients with crescentic glomerulonephritis, where misclassification as primary vasculitis could lead to aggressive immunosuppression without antiparasitic therapy.

The study thus reinforces that timely institution of antifilarial therapy—alone or combined with judicious immunosuppression can preserve renal function and improve outcomes. Given the rarity of such reports, a 6-year compilation of systematically analyzed cases is by itself an important strength and a valuable addition to the tropical nephrology literature. Certain limitations of the study such as small sample size (n=7) is inherent to the rarity of the condition, single-center and retrospective design, limited parasitological speciation (e.g., confirmation of W. bancrofti or Brugia), lack of data on the peripheral microfilaralemia are other limitations of the study.

These, however, do not undermine the significance of morphological observations, but rather highlight the need for larger, multicentric studies. Future research priorities include the development of prospective, multicenter registries for filariasis-associated kidney disease and the systematic collection of histopathological data in patients presenting with filarial chyluria to better define the indications for renal biopsy in this setting. In parallel, focused molecular and immunological studies are required to delineate the underlying pathogenic mechanisms, along with long-term outcome studies evaluating renal recovery following antifilarial therapy with or without adjunctive immunosuppression.